Problems associated with pharmacotherapy (in particular, medication errors and adverse
drug events) are frequent and are associated with increased costs for treatment. Analysis of …

Unfortunately, there is no endogenous marker for hepatic clearance that can be used as a
guide for drug dosing. In order to predict the kinetic behaviour of drugs in cirrhotic patients, …

The brain–gut-axis is an interdependent system affecting neural functions and controlling
our eating behaviour. In recent decades, neuroimaging techniques have facilitated its …

Importance Sleeve gastrectomy is increasingly used in the treatment of morbid obesity, but
its long-term outcome vs the standard Roux-en-Y gastric bypass procedure is unknown. …

Glucagon-like peptide-1-(7—36) amide (GLP-1) is an incretin hormone of the enteroinsular
axis. Recent experimental evidence in animals and healthy subjects suggests that GLP-1 …

This study evaluated the effect of physiological, TSH-guided, l-thyroxine treatment on serum
lipids and clinical symptoms in patients with subclinical hypothyroidism. Sixty-six women …

Glucagon-like peptide-1-(7–36)-amide (GLP-1) is involved in satiety control and glucose
homeostasis. Animal studies suggest a physiological role for GLP-1 in water and salt …

The human brain endothelial capillary cell line hCMEC/D3 has been developed recently as
a model for the human blood‐brain barrier. In this study a further characterization of this …

In vitro, both carbohydrate sugars and artificial sweeteners (AS) stimulate the secretion of
glucagon-like peptide-1 (GLP-1). It has been suggested that the gut tastes sugars and AS …

Objective Information on the frequency of drug combinations with the potential to induce
dangerous drug–drug interactions (DDIs) in patients discharged from the hospital is scarce. With …